SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma
Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients!
The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the Equity in Multiple Myeloma Bispecific Research and Access (EMMBRAce) Bispecific Antibody Implementation Group, aims to enhance the delivery and accessibility of bispecific antibodies for patients with multiple myeloma.
📄 Read the Consensus Framework here: Consensus Framework Document
The EMMBRAce group would like your feedback to refine this framework and project, ultimately improving treatment options for patients. Please take a moment to complete the survey and share it with your network.
🗓️ Survey Closes: February 27th
🔗 Take the Survey: https://qualtrics.ucl.ac.uk/jfe/form/SV_0Ilnj2WKuNB9lEa
Thank you for your valuable input and support!
